TRDA
Entrada Therapeutics, Inc. · Healthcare
CFO Kory James Wentworth sold $89K of Entrada Therapeutics, Inc.
Sold$88,932
$9.98Price
8,910Shares
−7%Stake
What TRDA did after the filing
- The stock from Mon, Nov 24 close, $9.89
- +6.4%
- S&P 500, same days
- +4.0%
Measured over 30 trading days, to the Jan 8 close.
Traded Fri, Nov 21. Filed Mon, Nov 24, 11:30 AM ET, during the session. Returns use the Nov 24 close and the Jan 8 close. Not investment advice.